Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 129

1.

Enhanced dissolution and oral bioavailability of tanshinone IIA base by solid dispersion system with low-molecular-weight chitosan.

Liu QY, Zhang ZH, Jin X, Jiang YR, Jia XB.

J Pharm Pharmacol. 2013 Jun;65(6):839-46. doi: 10.1111/jphp.12047. Epub 2013 Apr 9.

PMID:
23647677
2.

Novel Tanshinone II A ternary solid dispersion pellets prepared by a single-step technique: in vitro and in vivo evaluation.

Li J, Liu P, Liu JP, Zhang WL, Yang JK, Fan YQ.

Eur J Pharm Biopharm. 2012 Feb;80(2):426-32. doi: 10.1016/j.ejpb.2011.11.003. Epub 2011 Nov 18.

PMID:
22119664
3.

Preparation and physicochemical characterizations of tanshinone IIA solid dispersion.

Zhao X, Liu X, Gan L, Zhou C, Mo J.

Arch Pharm Res. 2011 Jun;34(6):949-59. doi: 10.1007/s12272-011-0612-3. Epub 2011 Jul 2.

PMID:
21725816
4.

Improvement in oral bioavailability and dissolution of tanshinone IIA by preparation of solid dispersions with porous silica.

Yan HM, Sun E, Cui L, Jia XB, Jin X.

J Pharm Pharmacol. 2015 Sep;67(9):1207-14. doi: 10.1111/jphp.12423. Epub 2015 May 5.

PMID:
25944009
5.

Preparation, characterization, and in vivo evaluation of tanshinone IIA solid dispersions with silica nanoparticles.

Jiang YR, Zhang ZH, Liu QY, Hu SY, Chen XY, Jia XB.

Int J Nanomedicine. 2013;8:2285-93. doi: 10.2147/IJN.S40374. Epub 2013 Jun 25.

6.

Preparation, characterization and in vitro/vivo evaluation of tectorigenin solid dispersion with improved dissolution and bioavailability.

Shuai S, Yue S, Huang Q, Wang W, Yang J, Lan K, Ye L.

Eur J Drug Metab Pharmacokinet. 2016 Aug;41(4):413-22. doi: 10.1007/s13318-015-0265-6. Epub 2015 Feb 11.

PMID:
25669445
7.

[Study on solid dispersion of copovidone-based tanshinone II(A)].

Jiang YR, Zhang ZH, Xia HJ, Jia XB.

Zhongguo Zhong Yao Za Zhi. 2013 Jan;38(2):174-8. Chinese.

PMID:
23672037
8.

Development of raloxifene-solid dispersion with improved oral bioavailability via spray-drying technique.

Tran TH, Poudel BK, Marasini N, Woo JS, Choi HG, Yong CS, Kim JO.

Arch Pharm Res. 2013 Jan;36(1):86-93. doi: 10.1007/s12272-013-0012-y.

PMID:
23325488
9.

Enhanced dissolution and bioavailability of grapefruit flavonoid Naringenin by solid dispersion utilizing fourth generation carrier.

Khan AW, Kotta S, Ansari SH, Sharma RK, Ali J.

Drug Dev Ind Pharm. 2015 May;41(5):772-9. doi: 10.3109/03639045.2014.902466. Epub 2014 Mar 26.

PMID:
24669978
10.

[Study on solid dispersion of binary vector of tanshinone II A].

Jiang Y, Zhang Z, Lu Y, Tang J, Ma T, Jia X.

Zhongguo Zhong Yao Za Zhi. 2012 May;37(10):1383-7. Chinese.

PMID:
22860446
11.

Preparation of osthole-polymer solid dispersions by hot-melt extrusion for dissolution and bioavailability enhancement.

Yun F, Kang A, Shan J, Zhao X, Bi X, Li J, Di L.

Int J Pharm. 2014 Apr 25;465(1-2):436-43. doi: 10.1016/j.ijpharm.2014.02.040. Epub 2014 Feb 25.

PMID:
24576810
12.

In vitro and in vivo studies on a novel solid dispersion of repaglinide using polyvinylpyrrolidone as the carrier.

Yin LF, Huang SJ, Zhu CL, Zhang SH, Zhang Q, Chen XJ, Liu QW.

Drug Dev Ind Pharm. 2012 Nov;38(11):1371-80. Epub 2012 Feb 2.

PMID:
22296267
13.

Dissolution properties and physical characterization of telmisartan-chitosan solid dispersions prepared by mechanochemical activation.

Zhong L, Zhu X, Luo X, Su W.

AAPS PharmSciTech. 2013 Jun;14(2):541-50. doi: 10.1208/s12249-013-9937-1. Epub 2013 Feb 21.

14.

Physicochemical and pharmacokinetic characterization of amorphous solid dispersion of tranilast with enhanced solubility in gastric fluid and improved oral bioavailability.

Onoue S, Kojo Y, Aoki Y, Kawabata Y, Yamauchi Y, Yamada S.

Drug Metab Pharmacokinet. 2012;27(4):379-87. Epub 2012 Jan 13.

15.

Fabrication and evaluation of pH-modulated solid dispersion for telmisartan by spray-drying technique.

Marasini N, Tran TH, Poudel BK, Cho HJ, Choi YK, Chi SC, Choi HG, Yong CS, Kim JO.

Int J Pharm. 2013 Jan 30;441(1-2):424-32. doi: 10.1016/j.ijpharm.2012.11.012. Epub 2012 Nov 19.

PMID:
23174408
16.

Enhanced bioavailability of sirolimus via preparation of solid dispersion nanoparticles using a supercritical antisolvent process.

Kim MS, Kim JS, Park HJ, Cho WK, Cha KH, Hwang SJ.

Int J Nanomedicine. 2011;6:2997-3009. doi: 10.2147/IJN.S26546. Epub 2011 Nov 24.

17.
18.

Amorphous solid dispersion of berberine with absorption enhancer demonstrates a remarkable hypoglycemic effect via improving its bioavailability.

Zhaojie M, Ming Z, Shengnan W, Xiaojia B, Hatch GM, Jingkai G, Li C.

Int J Pharm. 2014 Jun 5;467(1-2):50-9. doi: 10.1016/j.ijpharm.2014.03.017. Epub 2014 Mar 5.

PMID:
24607213
19.

Dispersion of daidzein with polyvinylpyrrolidone effects on dissolution rate and bioavailability.

Feng BL, Li HW, Zhou MY, Lu W.

Zhong Yao Cai. 2011 Apr;34(4):605-10.

PMID:
21809547
20.

Supplemental Content

Support Center